Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial. - Dei Cas A; Micheli MM; Aldigeri R; Gardini S; Ferrari-Pellegrini F; Perini M; Messa G; Antonini M; Spigoni V; Cinquegrani G; Vazzana A; Moretti V; et al. (Journal of endocrinological investigation, 2024)